Mandee Noval

Clinical Assistant Professor - Infectious Diseases

University of Maryland School of Pharmacy

United States

Research Interests

Explore related searches

Professors in United States Professors in Microbiology Microbiology professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Mandee Noval is a Clinical Assistant Professor in the Department of Infectious Diseases at the University of Maryland School of Pharmacy, USA. Her research focuses on antimicrobial stewardship, treatment strategies for multidrug-resistant infections, and the implications of bacteriuria in clinical practice. Recent articles examine the use of antibiotics at hospital discharge, treatment of carbapenem-resistant A. baumannii, and advanced monitoring techniques for infectious diseases.

Articles (9)

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (1)

Yohei Doi

Professor and Chair

Fujita Health University

JAPAN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Mandee Noval

Research Interests

Explore related searches

Contact this professor

About

Articles (9)

Evaluating the Follow-up of Post-discharge Positive Sterile Site Cultures and the Impact on Infection-Related Complications.

Early initiation of three-drug combinations for the treatment of carbapenem-resistant A. baumannii among COVID-19 patients

Antibiotic Use at Hospital Discharge and Outpatient Antimicrobial Stewardship

Evaluating the incidence of bacteriuria in female patients before and after implementation of external urinary collection devices.

Wohlfahrtiimonas chitiniclastica Monomicrobial Bacteremia in a Homeless Man.

The potential impact of discrepancies between automated susceptibility platforms and other testing metho`dologies for cefazolin in the treatment of Enterobacterales bloodstream infections.

Concurrent COVID-19 and Pneumocystis jirovecii pneumonia in a severely immunocompromised 25-year-old patient.

Evaluation of Fosphenytoin Therapeutic Drug Monitoring in the Neurocritical Care Unit.

The Battle Is on: New Beta-Lactams for the Treatment of Multidrug-Resistant Gram-Negative Organisms.

Collaborators (1)

Yohei Doi

Make your next move.